carbostyril has been researched along with Parkinsonian Disorders in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, KL; Jackowiak, EM | 1 |
| Espay, AJ; Gupta, HV; Sharma, VD | 1 |
| Krishnamurthy, S; Mishra, A | 1 |
| Chen, MH; Liou, YJ | 1 |
| Endo, T; Miyake, N; Miyamoto, S; Ogino, S; Yamaguchi, N | 1 |
| Germain, C; Pasquier de Franclieu, S; Petitjean, F | 1 |
| Babu, GN; Chandra, P; Kumar, R; Saddichha, S | 1 |
| Kim, TS; Lee, C; Pae, CU; Paik, IH | 2 |
| Sharma, A; Sorrell, JH | 1 |
| Ali, IM; Morris, HR; Wickremaratchi, M | 1 |
| Chen, YY; Hung, GC | 1 |
| Constant, EL; Emmanuel, H; Hermans, E; Jean-Jean, A; Koener, B; Maloteaux, JM | 1 |
| Dorado, P; Llerena, A; López-Torres, E; Peñas-Lledó, E; Salomón, J; Vicario, F | 1 |
14 other study(ies) available for carbostyril and Parkinsonian Disorders
| Article | Year |
|---|---|
Severe parkinsonism caused by brexpiprazole: A case report.
Topics: Aged; Antidepressive Agents; Depression; Dopamine Agonists; Female; Humans; Parkinsonian Disorders; Quinolones; Thiophenes | 2019 |
Copulatory Dyskinesia: Pathognomonic Manifestation of Tardive Dyskinesia.
Topics: Adrenergic beta-Antagonists; Aged; Aripiprazole; Clonazepam; Deprescriptions; Depressive Disorder; Drug Substitution; GABA Modulators; Humans; Male; Parkinsonian Disorders; Pelvis; Propranolol; Quinolones; Serotonin Agents; Tardive Dyskinesia; Tetrabenazine; Thiophenes; Treatment Failure; Valine | 2020 |
Rebamipide Mitigates Impairments in Mitochondrial Function and Bioenergetics with α-Synuclein Pathology in 6-OHDA-Induced Hemiparkinson's Model in Rats.
Topics: Administration, Oral; Alanine; alpha-Synuclein; Animals; Antioxidants; Antiparkinson Agents; Apoptosis; Dose-Response Relationship, Drug; Energy Metabolism; Functional Laterality; Male; Mitochondria; Motor Activity; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Quinolones; Random Allocation; Rats; Substantia Nigra | 2019 |
Aripiprazole-associated acute dystonia, akathisia, and parkinsonism in a patient with bipolar I disorder.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dystonia; Female; Humans; Parkinsonian Disorders; Piperazines; Quinolones | 2013 |
Successful treatment of delusional disorder with low-dose aripiprazole.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Middle Aged; Parkinsonian Disorders; Piperazines; Quinolones; Schizophrenia, Paranoid; Treatment Outcome | 2008 |
[Aripiprazole induced Parkinsonism: A case report].
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Female; Humans; Parkinsonian Disorders; Piperazines; Quinolones; Schizophrenia, Paranoid | 2009 |
Aripiprazole associated with acute dystonia, akathisia, and parkinsonism in a single patient.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Depression; Dystonia; Female; Fluoxetine; Humans; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Quinolones | 2012 |
Effect of aripiprazole for a patient with psychotic symptoms and parkinsonism associated with delayed-sequelae of carbon monoxide intoxication.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Carbon Monoxide Poisoning; Female; Humans; Mental Disorders; Parkinsonian Disorders; Piperazines; Quinolones | 2005 |
Aripiprazole-induced parkinsonism.
Topics: Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Humans; Male; Middle Aged; Parkinsonian Disorders; Piperazines; Quinolones | 2006 |
Effect of aripiprazole for a patient with psychotic symptoms and parkinsonism associated with delayed-sequelae of carbon monoxide intoxication.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brain; Carbon Monoxide Poisoning; Female; Humans; Parkinsonian Disorders; Piperazines; Psychoses, Substance-Induced; Quinolones; Treatment Outcome | 2006 |
Aripiprazole associated with severe exacerbation of Parkinson's disease.
Topics: Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Quinolones | 2006 |
Extrapyramidal side effects associated with aripiprazole administration in a schizophrenic patient.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Humans; Male; Parkinsonian Disorders; Piperazines; Quinolones; Schizophrenia | 2007 |
Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine D2 Receptor Antagonists; Female; Humans; Middle Aged; Parkinsonian Disorders; Piperazines; Quinolones; Receptors, Dopamine D2 | 2007 |
Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms.
Topics: Adolescent; Alleles; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Parkinsonian Disorders; Piperazines; Polymorphism, Genetic; Psychotic Disorders; Quinolones; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risk Factors | 2008 |